These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 19633967

  • 41. Brain atrophy in clinically early relapsing-remitting multiple sclerosis.
    Chard DT, Griffin CM, Parker GJ, Kapoor R, Thompson AJ, Miller DH.
    Brain; 2002 Feb; 125(Pt 2):327-37. PubMed ID: 11844733
    [Abstract] [Full Text] [Related]

  • 42. Complementary roles of grey matter MTR and T2 lesions in predicting progression in early PPMS.
    Tur C, Khaleeli Z, Ciccarelli O, Altmann DR, Cercignani M, Miller DH, Thompson AJ.
    J Neurol Neurosurg Psychiatry; 2011 Apr; 82(4):423-8. PubMed ID: 20974648
    [Abstract] [Full Text] [Related]

  • 43. 3T deep gray matter T2 hypointensity correlates with disability over time in stable relapsing-remitting multiple sclerosis: a 3-year pilot study.
    Zhang Y, Metz LM, Yong VW, Mitchell JR.
    J Neurol Sci; 2010 Oct 15; 297(1-2):76-81. PubMed ID: 20708201
    [Abstract] [Full Text] [Related]

  • 44. Early imaging predicts later cognitive impairment in primary progressive multiple sclerosis.
    Penny S, Khaleeli Z, Cipolotti L, Thompson A, Ron M.
    Neurology; 2010 Feb 16; 74(7):545-52. PubMed ID: 20157157
    [Abstract] [Full Text] [Related]

  • 45. Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis.
    Datta G, Colasanti A, Rabiner EA, Gunn RN, Malik O, Ciccarelli O, Nicholas R, Van Vlierberghe E, Van Hecke W, Searle G, Santos-Ribeiro A, Matthews PM.
    Brain; 2017 Nov 01; 140(11):2927-2938. PubMed ID: 29053775
    [Abstract] [Full Text] [Related]

  • 46. MRI techniques and cognitive impairment in the early phase of relapsing-remitting multiple sclerosis.
    Zivadinov R, De Masi R, Nasuelli D, Bragadin LM, Ukmar M, Pozzi-Mucelli RS, Grop A, Cazzato G, Zorzon M.
    Neuroradiology; 2001 Apr 01; 43(4):272-8. PubMed ID: 11338408
    [Abstract] [Full Text] [Related]

  • 47. Correlation of magnetization transfer and diffusion magnetic resonance imaging in multiple sclerosis.
    Otaduy MC, Callegaro D, Bacheschi LA, Leite CC.
    Mult Scler; 2006 Dec 01; 12(6):754-9. PubMed ID: 17263003
    [Abstract] [Full Text] [Related]

  • 48. Magnetization transfer ratio histogram analysis of gray matter in relapsing-remitting multiple sclerosis.
    Ge Y, Grossman RI, Udupa JK, Babb JS, Kolson DL, McGowan JC.
    AJNR Am J Neuroradiol; 2001 Mar 01; 22(3):470-5. PubMed ID: 11237968
    [Abstract] [Full Text] [Related]

  • 49. Evidence of early cortical atrophy in MS: relevance to white matter changes and disability.
    De Stefano N, Matthews PM, Filippi M, Agosta F, De Luca M, Bartolozzi ML, Guidi L, Ghezzi A, Montanari E, Cifelli A, Federico A, Smith SM.
    Neurology; 2003 Apr 08; 60(7):1157-62. PubMed ID: 12682324
    [Abstract] [Full Text] [Related]

  • 50. Loss of retinal nerve fibre layer axons indicates white but not grey matter damage in early multiple sclerosis.
    Young KL, Brandt AU, Petzold A, Reitz LY, Lintze F, Paul F, Martin R, Schippling S.
    Eur J Neurol; 2013 May 08; 20(5):803-11. PubMed ID: 23369013
    [Abstract] [Full Text] [Related]

  • 51. Gray matter N-acetyl aspartate deficits in secondary progressive but not relapsing-remitting multiple sclerosis.
    Adalsteinsson E, Langer-Gould A, Homer RJ, Rao A, Sullivan EV, Lima CA, Pfefferbaum A, Atlas SW.
    AJNR Am J Neuroradiol; 2003 May 08; 24(10):1941-5. PubMed ID: 14625214
    [Abstract] [Full Text] [Related]

  • 52. Magnetic resonance fingerprinting in multiple sclerosis.
    Ontaneda D, Gulani V, Deshmane A, Shah A, Guruprakash DK, Jiang Y, Ma D, Fisher E, Rudick RA, Raza P, Kilbane M, Cohen JA, Sakaie K, Lowe MJ, Griswold MA, Nakamura K.
    Mult Scler Relat Disord; 2023 Nov 08; 79():105024. PubMed ID: 37783196
    [Abstract] [Full Text] [Related]

  • 53. Characterization of multiple sclerosis neuroinflammation and neurodegeneration with relaxation and diffusion basis spectrum imaging.
    Vavasour IM, Sun P, Graf C, Yik JT, Kolind SH, Li DK, Tam R, Sayao AL, Schabas A, Devonshire V, Carruthers R, Traboulsee A, Moore GW, Song SK, Laule C.
    Mult Scler; 2022 Mar 08; 28(3):418-428. PubMed ID: 34132126
    [Abstract] [Full Text] [Related]

  • 54. Effect of siponimod on magnetic resonance imaging measures of neurodegeneration and myelination in secondary progressive multiple sclerosis: Gray matter atrophy and magnetization transfer ratio analyses from the EXPAND phase 3 trial.
    Arnold DL, Piani-Meier D, Bar-Or A, Benedict RH, Cree BA, Giovannoni G, Gold R, Vermersch P, Arnould S, Dahlke F, Hach T, Ritter S, Karlsson G, Kappos L, Fox RJ, EXPAND Clinical Investigators.
    Mult Scler; 2022 Sep 08; 28(10):1526-1540. PubMed ID: 35261318
    [Abstract] [Full Text] [Related]

  • 55. Deep gray matter changes in relapsing-remitting multiple sclerosis detected by multi-parametric, high-resolution magnetic resonance imaging (MRI).
    Al-Radaideh A, Athamneh I, Alabadi H, Hbahbih M.
    Eur Radiol; 2021 Feb 08; 31(2):706-715. PubMed ID: 32851443
    [Abstract] [Full Text] [Related]

  • 56. Brain atrophy and magnetization transfer ratio following methylprednisolone in multiple sclerosis: short-term changes and long-term implications.
    Fox RJ, Fisher E, Tkach J, Lee JC, Cohen JA, Rudick RA.
    Mult Scler; 2005 Apr 08; 11(2):140-5. PubMed ID: 15794385
    [Abstract] [Full Text] [Related]

  • 57. Cervical cord area is associated with infratentorial grey and white matter volume predominantly in relapsing-remitting multiple sclerosis: A study using semi-automated cord volumetry and voxel-based morphometry.
    Bellenberg B, Schneider R, Weiler F, Suchan B, Haghikia A, Hoffjan S, Gold R, Köster O, Lukas C.
    Mult Scler Relat Disord; 2015 May 08; 4(3):264-72. PubMed ID: 26008944
    [Abstract] [Full Text] [Related]

  • 58. A semiautomated measure of whole-brain atrophy in multiple sclerosis.
    Bermel RA, Sharma J, Tjoa CW, Puli SR, Bakshi R.
    J Neurol Sci; 2003 Apr 15; 208(1-2):57-65. PubMed ID: 12639726
    [Abstract] [Full Text] [Related]

  • 59. Voxel-wise magnetization transfer imaging study of effects of natalizumab and IFNβ-1a in multiple sclerosis.
    Zivadinov R, Dwyer MG, Hussein S, Carl E, Kennedy C, Andrews M, Hojnacki D, Heininen-Brown M, Willis L, Cherneva M, Bergsland N, Weinstock-Guttman B.
    Mult Scler; 2012 Aug 15; 18(8):1125-34. PubMed ID: 22194217
    [Abstract] [Full Text] [Related]

  • 60. Gray and white matter volume changes in early RRMS: a 2-year longitudinal study.
    Tiberio M, Chard DT, Altmann DR, Davies G, Griffin CM, Rashid W, Sastre-Garriga J, Thompson AJ, Miller DH.
    Neurology; 2005 Mar 22; 64(6):1001-7. PubMed ID: 15781816
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.